ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
65,523.32
6.46%
S&P 500
5,300.71
1.03%
Dow Jones
39,837.34
0.71%
US Dollar vs Yen
155.001
-0.96%
Brent Oil
82.62
0.08%
Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Pacific Biosciences of California Inc (PACB)

  7. Pacific Biosciences of California Inc (PACB) ニュース

PACB

Pacific Biosciences of C... (PACB)

Pacific Biosciences of California Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:PACB
日付受信時刻ニュースソース見出しコード企業名
2024/05/1522 : 45PR Newswire (US)Ambry Genetics and PacBio Announce Collaboration to Sequence Up to 7,000 Human Genomes Aimed at Providing Answers for Families Battling Rare DiseasesNASDAQ:PACBPacific Biosciences of California Inc
2024/05/1005 : 33Edgar (US Regulatory)Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuersNASDAQ:PACBPacific Biosciences of California Inc
2024/05/1005 : 21Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PACBPacific Biosciences of California Inc
2024/05/1005 : 12Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PACBPacific Biosciences of California Inc
2024/05/1005 : 05PR Newswire (US)PacBio Announces First Quarter 2024 Financial ResultsNASDAQ:PACBPacific Biosciences of California Inc
2024/04/1621 : 05PR Newswire (US)PacBio Announces Preliminary First Quarter 2024 Revenue and Updates 2024 Revenue GuidanceNASDAQ:PACBPacific Biosciences of California Inc
2024/03/2721 : 00PR Newswire (US)Estonia National Biobank Selects PacBio to Sequence 10,000 Whole GenomesNASDAQ:PACBPacific Biosciences of California Inc
2024/03/2305 : 30PR Newswire (US)PacBio Grants Equity Incentive Award to New EmployeeNASDAQ:PACBPacific Biosciences of California Inc
2024/03/1222 : 05PR Newswire (US)PacBio Announces PureTarget™ Repeat Expansion Panel, Expanding its Portfolio of End-to-End Clinical Research SolutionsNASDAQ:PACBPacific Biosciences of California Inc
2024/03/0707 : 36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PACBPacific Biosciences of California Inc
2024/03/0707 : 30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PACBPacific Biosciences of California Inc
2024/03/0707 : 26Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PACBPacific Biosciences of California Inc
2024/03/0707 : 22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PACBPacific Biosciences of California Inc
2024/03/0508 : 32Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PACBPacific Biosciences of California Inc
2024/03/0508 : 22Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PACBPacific Biosciences of California Inc
2024/02/2706 : 55Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PACBPacific Biosciences of California Inc
2024/02/2706 : 36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PACBPacific Biosciences of California Inc
2024/02/2706 : 25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PACBPacific Biosciences of California Inc
2024/02/2706 : 19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PACBPacific Biosciences of California Inc
2024/02/2706 : 05PR Newswire (US)PacBio to Present at Upcoming Investor ConferencesNASDAQ:PACBPacific Biosciences of California Inc
2024/02/2208 : 25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PACBPacific Biosciences of California Inc
2024/02/2208 : 20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PACBPacific Biosciences of California Inc
2024/02/2208 : 17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PACBPacific Biosciences of California Inc
2024/02/2208 : 07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PACBPacific Biosciences of California Inc
2024/02/2106 : 17Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PACBPacific Biosciences of California Inc
2024/02/1707 : 54Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PACBPacific Biosciences of California Inc
2024/02/1707 : 52Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PACBPacific Biosciences of California Inc
2024/02/1707 : 06Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PACBPacific Biosciences of California Inc
2024/02/1606 : 07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PACBPacific Biosciences of California Inc
2024/02/1606 : 05PR Newswire (US)PacBio Announces Fourth Quarter and Fiscal Year 2023 Financial ResultsNASDAQ:PACBPacific Biosciences of California Inc
 Showing the most relevant articles for your search:NASDAQ:PACB

最近閲覧した銘柄

LSE
49VV
Granite Mas.b1
LSE
0ICP
Dover
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有